In the Republic of Ireland, the use of the Oxford-AstraZeneca vaccine has been discontinued. Following reports of severe blood clotting incidents in adults in Norway, the National Immunization Advisory Committee (NIAC) recommended the change. Stephen Donnelly, Ireland's Minister for Health, said it was a "precautionary step" in a statement. According to the World Health Organization, there is no correlation between the vaccine and an increased risk of blood clots. Denmark and Norway halted the use of vaccines last week. The World Health Organization said on Friday that there is no proof that the vaccine triggers blood clots, so countries do not stop using it.
Dr. Ronan Glynn, Ireland's Deputy Chief Medical Officer, said earlier on Sunday that the Norwegian Medicines Agency had provided new details on Saturday night. There has been no conclusion that there is any connection between the AstraZeneca Covid-19 vaccine and these cases, he explained. The National Immunization Advisory Committee, working on the precautionary principle and awaiting further details, has recommended deferring the Covid-19 vaccine AstraZeneca vaccination program in Ireland for the time being. According to AstraZeneca, a review of safety data covering more than 17 million doses of the vaccine administered found no signs of an elevated risk of the conditions in question, and clinical trials revealed no trends or patterns.